Publications by authors named "Gillian R Slator"

Claim this Profile
F
First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models.
Julie A Kelly, Noreen T Boyle, Natalie Cole, Gillian R Slator, M Alessandra Colivicchi

Neuropharmacology· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone.
Gaia A Scalabrino, Nicola Hogan, Kathy M O'Boyle, Gillian R Slator, Daniel J Gregg

Neuropharmacology· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II.
Julie A Kelly, Gaia A Scalabrino, Gillian R Slator, Aoife A Cullen, John F Gilmer

Biochem J· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologically distinct binding sites in rat brain for [3H]thyrotropin-releasing hormone (TRH) and [3H][3-methyl-histidine(2)]TRH.
Julie A Kelly, Gillian R Slator, Kathy M O'Boyle

Biochem Pharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis